Fed Governor Adriana Kugler to resign
Cencora, Inc. (NYSE:COR), a prominent player in the Healthcare Providers & Services industry with a market capitalization of $50.5 billion, recently saw a notable transaction involving its Senior Vice President and Chief Accounting Officer, Krikorian Lazarus. According to a recent SEC filing, Lazarus sold 2,000 shares of Cencora common stock on March 10. The shares were sold at a price of $260.06 each, totaling $520,120, with the stock trading near its 52-week high after gaining nearly 17% year-to-date.
Following this transaction, Lazarus retains ownership of 20,154 shares in the company. This sale is part of the regular reporting required for company insiders, providing investors with transparency regarding insider trading activities. According to InvestingPro analysis, Cencora maintains a "GOOD" financial health score and shows signs of being slightly undervalued based on its Fair Value assessment. Subscribers can access 13 additional ProTips and a comprehensive Pro Research Report for deeper insights into Cencora’s financial outlook.
In other recent news, Cencora, Inc. has completed the acquisition of Retina Consultants of America for $4.4 billion, leading the company to raise its fiscal year 2025 adjusted earnings per share (EPS) guidance. The revised EPS is now projected to be between $15.15 and $15.45, up from the previous estimate of $14.80 to $15.10. Additionally, Leerink Partners has increased Cencora’s stock price target to $301, maintaining an Outperform rating following strong first-quarter results. This adjustment reflects continued confidence in Cencora’s growth potential, particularly in its U.S. Healthcare segment.
In other developments, Cencora’s shareholders have approved executive compensation and elected directors at the recent Annual Meeting. The ratification of Ernst & Young LLP as the company’s independent accounting firm was also confirmed. Meanwhile, two long-standing board members, Richard W. Gochnauer and Kathleen W. Hyle, have announced their retirement, effective at the next Annual Meeting. This will reduce the board’s size from 13 to 11 members. These updates reflect Cencora’s ongoing strategic and governance activities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.